Where Will Cisco Systems Stock Be in 10 Years?
Cisco Systems, Inc. (NASDAQ:CSCO) has enjoyed its position as a…
Sell
42
MRNA Quote, Financials, Valuation and Earnings
Last price:
$43.18
Seasonality move
:
11.47%
Day range:
$42.86 - $48.92
52-week range:
$35.80 - $170.47
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.64x
P/B ratio:
1.53x
Volume:
22.3M
Avg. volume:
8.4M
1-year change:
-57.23%
Market cap:
$18.3B
Revenue:
$6.8B
EPS (TTM):
-$5.82
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $48M | $274M | $17.7B | $18.9B | $6.8B | |
| Revenue Growth (YoY) | -60.82% | 470.83% | 6372.99% | 6.42% | -64.22% | |
| Cost of Revenues | -- | $8M | $2.6B | $5.4B | $4.7B | |
| Gross Profit | $48M | $266M | $15.1B | $13.5B | $2.1B | |
| Gross Profit Margin | -- | 97.08% | 85.25% | 71.31% | 30.52% | |
| R&D Expenses | $496M | $1.4B | $2B | $3.3B | $4.8B | |
| Selling, General & Admin | $110M | $188M | $567M | $1.1B | $1.5B | |
| Other Inc / (Exp) | -$8M | -$6M | -$29M | -$16M | -$86M | |
| Operating Expenses | $594M | $1B | $1.8B | $4B | $6.3B | |
| Operating Income | -$546M | -$763M | $13.3B | $9.4B | -$4.2B | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$515M | -$744M | $13.3B | $9.6B | -$3.9B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1M | $3M | $1.1B | $1.2B | $772M | |
| Net Income to Company | -$514M | -$747M | $12.2B | $8.4B | -$4.7B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$514M | -$747M | $12.2B | $8.4B | -$4.7B | |
| Basic EPS (Cont. Ops) | -$1.55 | -$1.96 | $30.31 | $21.26 | -$12.33 | |
| Diluted EPS (Cont. Ops) | -$1.55 | -$1.96 | $28.29 | $20.12 | -$12.33 | |
| Weighted Average Basic Share | $331M | $381M | $403M | $394M | $382M | |
| Weighted Average Diluted Share | $331M | $381M | $431M | $416M | $382M | |
| EBITDA | -$515M | -$732M | $13.5B | $10B | -$3.3B | |
| EBIT | -$546M | -$763M | $13.3B | $9.6B | -$3.9B | |
| Revenue (Reported) | $48M | $274M | $17.7B | $18.9B | $6.8B | |
| Operating Income (Reported) | -$546M | -$763M | $13.3B | $9.4B | -$4.2B | |
| Operating Income (Adjusted) | -$546M | -$763M | $13.3B | $9.6B | -$3.9B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $12M | $4.8B | $3.2B | $1.8B | $1.9B | |
| Revenue Growth (YoY) | -10.03% | 40141.67% | -33.32% | -44.5% | 3.81% | |
| Cost of Revenues | -- | $722M | $1.1B | $2.2B | $514M | |
| Gross Profit | $12M | $4.1B | $2.1B | -$454M | $1.3B | |
| Gross Profit Margin | -- | 85.05% | 65.84% | -25.41% | 72.29% | |
| R&D Expenses | $344M | $521M | $820M | $1.2B | $1.1B | |
| Selling, General & Admin | $48M | $168M | $278M | $442M | $281M | |
| Other Inc / (Exp) | -$1M | -$6M | $1M | -$41M | -$6M | |
| Operating Expenses | $247M | $549M | $954M | $1.6B | $1.4B | |
| Operating Income | -$235M | $3.6B | $1.2B | -$2B | -$70M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$232M | $3.6B | $1.2B | -$2B | $21M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1M | $219M | $174M | $1.7B | $8M | |
| Net Income to Company | -$233M | $3.3B | $1B | -$3.6B | $13M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$233M | $3.3B | $1B | -$3.6B | $13M | |
| Basic EPS (Cont. Ops) | -$0.59 | $8.27 | $2.67 | -$9.53 | $0.03 | |
| Diluted EPS (Cont. Ops) | -$0.59 | $7.70 | $2.53 | -$9.53 | $0.03 | |
| Weighted Average Basic Share | $395M | $404M | $390M | $381M | $385M | |
| Weighted Average Diluted Share | $395M | $434M | $412M | $381M | $399M | |
| EBITDA | -$221M | $3.6B | $1.3B | -$1.7B | $79M | |
| EBIT | -$230M | $3.6B | $1.2B | -$1.9B | $27M | |
| Revenue (Reported) | $12M | $4.8B | $3.2B | $1.8B | $1.9B | |
| Operating Income (Reported) | -$235M | $3.6B | $1.2B | -$2B | -$70M | |
| Operating Income (Adjusted) | -$230M | $3.6B | $1.2B | -$1.9B | $27M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $55.5M | $11B | $20.7B | $9.1B | $5.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $1.7B | $4.5B | $5.7B | $1.7B | |
| Gross Profit | -- | $9.3B | $16.2B | $3.4B | $3.4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $728.6M | $2.1B | $2.7B | $4.7B | $4.8B | |
| Selling, General & Admin | $135.1M | $445M | $958M | $1.5B | $1.3B | |
| Other Inc / (Exp) | -$7.3M | -$10M | -$33M | -$55M | -$73M | |
| Operating Expenses | $673.4M | $1.7B | $3B | $6.1B | $6.1B | |
| Operating Income | -$617.9M | $7.6B | $13.3B | -$2.7B | -$2.7B | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$596.7M | $7.6B | $13.3B | -$2.4B | -$2.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $526K | $543M | $1.6B | $1.1B | -$129M | |
| Net Income to Company | -$597.3M | $7.1B | $11.8B | -$3.5B | -$2.2B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$597.3M | $7.1B | $11.8B | -$3.5B | -$2.2B | |
| Basic EPS (Cont. Ops) | -$1.62 | $17.56 | $29.34 | -$9.14 | -$5.80 | |
| Diluted EPS (Cont. Ops) | -$1.62 | $16.31 | $27.64 | -$9.35 | -$5.82 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$593.7M | $7.8B | $13.7B | -$1.8B | -$2B | |
| EBIT | -$626.7M | $7.6B | $13.3B | -$2.3B | -$2.3B | |
| Revenue (Reported) | $55.5M | $11B | $20.7B | $9.1B | $5.1B | |
| Operating Income (Reported) | -$617.9M | $7.6B | $13.3B | -$2.7B | -$2.7B | |
| Operating Income (Adjusted) | -$626.7M | $7.6B | $13.3B | -$2.3B | -$2.3B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $45M | $10.8B | $13.7B | $3.9B | $2.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $1.7B | $3.5B | $3.8B | $725M | |
| Gross Profit | $45M | $9.1B | $10.2B | $177M | $1.5B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $611M | $1.3B | $2.1B | $3.4B | $3.4B | |
| Selling, General & Admin | $109M | $366M | $757M | $1.1B | $823M | |
| Other Inc / (Exp) | -- | -$10M | -$14M | -$53M | -$40M | |
| Operating Expenses | $533M | $1.2B | $2.4B | $4.4B | $4.2B | |
| Operating Income | -$488M | $7.9B | $7.8B | -$4.2B | -$2.7B | |
| Net Interest Expenses | -- | $2M | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$473M | $7.9B | $7.9B | -$4B | -$2.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1M | $541M | $1B | $919M | $18M | |
| Net Income to Company | -$474M | $7.3B | $6.9B | -$4.9B | -$2.4B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$474M | $7.3B | $6.9B | -$4.9B | -$2.4B | |
| Basic EPS (Cont. Ops) | -$1.25 | $18.25 | $17.31 | -$12.95 | -$6.37 | |
| Diluted EPS (Cont. Ops) | -$1.25 | $17.00 | $16.35 | -$12.96 | -$6.37 | |
| Weighted Average Basic Share | $1.1B | $1.2B | $1.2B | $1.1B | $1.2B | |
| Weighted Average Diluted Share | $1.1B | $1.3B | $1.3B | $1.2B | $1.2B | |
| EBITDA | -$443M | $8B | $8.2B | -$3.6B | -$2.3B | |
| EBIT | -$467M | $7.9B | $7.9B | -$4B | -$2.4B | |
| Revenue (Reported) | $45M | $10.8B | $13.7B | $3.9B | $2.2B | |
| Operating Income (Reported) | -$488M | $7.9B | $7.8B | -$4.2B | -$2.7B | |
| Operating Income (Adjusted) | -$467M | $7.9B | $7.9B | -$4B | -$2.4B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $235.9M | $2.6B | $6.8B | $3.2B | $2.9B | |
| Short Term Investments | $867.1M | $2B | $3.9B | $6.7B | $5.7B | |
| Accounts Receivable, Net | $9.5M | $1.4B | $3.2B | $1.4B | $892M | |
| Inventory | -- | $47M | $1.4B | $949M | $202M | |
| Prepaid Expenses | $8.5M | $224M | $554M | $851M | $350M | |
| Other Current Assets | -- | $11M | $26M | $44M | $88M | |
| Total Current Assets | $1.1B | $6.3B | $16.1B | $13.4B | $10.3B | |
| Property Plant And Equipment | $287.9M | $387M | $1.4B | $2.1B | $2.7B | |
| Long-Term Investments | $160M | $639M | $6.8B | $8.4B | $4.7B | |
| Goodwill | -- | -- | -- | -- | $52M | |
| Other Intangibles | -- | -- | -- | -- | $44M | |
| Other Long-Term Assets | $12.7M | $13M | $46M | $946M | $181M | |
| Total Assets | $1.6B | $7.3B | $24.7B | $25.9B | $18.4B | |
| Accounts Payable | $7.1M | $18M | $302M | $487M | $520M | |
| Accrued Expenses | $40.2M | $375M | $1.3B | $1.9B | $997M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $30M | $211M | $196M | $25M | |
| Other Current Liabilities | $5.1M | $4M | $14M | $53M | $41M | |
| Total Current Liabilities | $143.1M | $4.4B | $9.1B | $4.9B | $3B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $414.6M | $4.8B | $10.5B | $6.7B | $4.6B | |
| Common Stock | $34K | -- | -- | -- | -- | |
| Other Common Equity Adj | $1.8M | $3M | -$24M | -$370M | -$123M | |
| Common Equity | $1.2B | $2.6B | $14.1B | $19.1B | $13.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.2B | $2.6B | $14.1B | $19.1B | $13.9B | |
| Total Liabilities and Equity | $1.6B | $7.3B | $24.7B | $25.9B | $18.4B | |
| Cash and Short Terms | $1.1B | $4.6B | $10.7B | $9.9B | $8.6B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.5B | $5.6B | $3B | $2.9B | $1.6B | |
| Short Term Investments | $1.8B | $3.4B | $5.3B | $4.6B | $5.2B | |
| Accounts Receivable, Net | $203.4M | $3.1B | $2.7B | $1.9B | $1.6B | |
| Inventory | -- | $965M | $2.1B | $487M | $412M | |
| Prepaid Expenses | $86.4M | $261M | $889M | $497M | $505M | |
| Other Current Assets | -- | $43M | $85M | $96M | $46M | |
| Total Current Assets | $3.6B | $13.4B | $14.3B | $10.8B | $9.7B | |
| Property Plant And Equipment | $368.6M | $960M | $2.1B | $2.7B | $3.2B | |
| Long-Term Investments | $692M | $6.4B | $8.7B | $5.4B | $2.4B | |
| Goodwill | -- | -- | -- | $52M | $52M | |
| Other Intangibles | -- | -- | -- | $45M | $41M | |
| Other Long-Term Assets | $13.1M | $15M | $52M | $240M | $85M | |
| Total Assets | $4.7B | $20.9B | $26.1B | $19.5B | $15.8B | |
| Accounts Payable | $20.5M | $87M | $330M | $494M | $373M | |
| Accrued Expenses | $160M | $971M | $1.7B | $1.8B | $729M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $4.7M | $240M | $260M | $183M | $51M | |
| Other Current Liabilities | $5M | $12M | $293M | $56M | $18M | |
| Total Current Liabilities | $1.5B | $10B | $6.8B | $4.4B | $2.2B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.9B | $10.8B | $8.1B | $6B | $3.9B | |
| Common Stock | $40K | -- | -- | -- | -- | |
| Other Common Equity Adj | $4.8M | $31M | -$351M | -$211M | $11M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $2.8B | $10.1B | $18B | $13.5B | $11.9B | |
| Total Liabilities and Equity | $4.7B | $20.9B | $26.1B | $19.5B | $15.8B | |
| Cash and Short Terms | $3.3B | $8.9B | $8.3B | $7.6B | $6.9B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$514M | -$747M | $12.2B | $8.4B | -$4.7B | |
| Depreciation & Amoritzation | $31M | $31M | $232M | $348M | $621M | |
| Stock-Based Compensation | $81M | $93M | $142M | $226M | $305M | |
| Change in Accounts Receivable | $7M | -$1.4B | -$1.8B | $1.8B | $493M | |
| Change in Inventories | -- | -$47M | -$1.4B | $492M | $747M | |
| Cash From Operations | -$459M | $2B | $13.6B | $5B | -$3.1B | |
| Capital Expenditures | $32M | $68M | $284M | $400M | $707M | |
| Cash Acquisitions | -- | -- | -- | -- | -$85M | |
| Cash From Investing | -$15M | -$1.7B | -$8.5B | -$5.2B | $4.2B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -$857M | -$3.3B | -$1.2B | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $52M | $2B | -$873M | -$3.4B | -$1.4B | |
| Beginning Cash (CF) | $670M | $248M | $2.6B | $6.9B | $3.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$422M | $2.4B | $4.2B | -$3.6B | -$289M | |
| Ending Cash (CF) | $248M | $2.6B | $6.9B | $3.2B | $2.9B | |
| Levered Free Cash Flow | -$491M | $2B | $13.3B | $4.6B | -$3.8B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$233M | $3.3B | $1B | -$3.6B | $13M | |
| Depreciation & Amoritzation | $9M | $70M | $113M | $249M | $52M | |
| Stock-Based Compensation | $22M | $40M | $70M | $77M | $112M | |
| Change in Accounts Receivable | -$157M | -$1.1B | -$4M | -$1.6B | -$1.4B | |
| Change in Inventories | -- | -$322M | -$156M | $228M | -$11M | |
| Cash From Operations | $893M | $3.3B | $252M | -$1.6B | -$1.6B | |
| Capital Expenditures | $19M | $99M | $89M | $140M | $151M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.2B | -$3.3B | $945M | $789M | $721M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | $62M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -$1B | $1M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $30M | -$2M | -$1B | -$58M | $11M | |
| Beginning Cash (CF) | $1.8B | $5.6B | $2.9B | $3.8B | $2.5B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$256M | -$53M | $156M | -$869M | -$833M | |
| Ending Cash (CF) | $1.5B | $5.6B | $3B | $3B | $1.6B | |
| Levered Free Cash Flow | $874M | $3.2B | $163M | -$1.7B | -$1.7B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$597.3M | $7.1B | $11.8B | -$3.5B | -$2.2B | |
| Depreciation & Amoritzation | $33M | $161M | $346M | $499M | $331M | |
| Stock-Based Compensation | $87.2M | $131M | $201M | $288M | $404M | |
| Change in Accounts Receivable | -$182.4M | -$3B | $447M | $829M | $302M | |
| Change in Inventories | -- | -$965M | -$1.1B | $1.6B | $77M | |
| Cash From Operations | $663.9M | $11.6B | $6.6B | -$2.1B | -$3.2B | |
| Capital Expenditures | $51.1M | $188M | $428M | $579M | $749M | |
| Cash Acquisitions | -- | -- | -- | -$85M | -- | |
| Cash From Investing | -$1.4B | -$7.6B | -$5.3B | $3.7B | $2B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -$3.8B | -$1.6B | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $2B | $44M | -$3.9B | -$1.7B | -$50M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.3B | $4B | -$2.5B | -$88M | -$1.3B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $612.8M | $11.4B | $6.2B | -$2.7B | -$4B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$474M | $7.3B | $6.9B | -$4.9B | -$2.4B | |
| Depreciation & Amoritzation | $24M | $154M | $268M | $419M | $129M | |
| Stock-Based Compensation | $67M | $105M | $164M | $226M | $325M | |
| Change in Accounts Receivable | -$185M | -$1.8B | $480M | -$481M | -$672M | |
| Change in Inventories | -- | -$918M | -$636M | $462M | -$208M | |
| Cash From Operations | $763M | $10.3B | $3.3B | -$3.7B | -$3.8B | |
| Capital Expenditures | $44M | $164M | $308M | $487M | $529M | |
| Cash Acquisitions | -- | -- | -- | -$85M | -- | |
| Cash From Investing | -$1.5B | -$7.4B | -$4.1B | $4.7B | $2.5B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -$2.9B | -$1.2B | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $2B | -- | -$3B | -$1.3B | $59M | |
| Beginning Cash (CF) | $2.4B | $13.7B | $14.8B | $10.5B | $7.5B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.3B | $2.9B | -$3.8B | -$264M | -$1.3B | |
| Ending Cash (CF) | $3.7B | $16.6B | $11B | $10.2B | $6.2B | |
| Levered Free Cash Flow | $719M | $10.1B | $3B | -$4.2B | -$4.4B | |
Get MRNA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MRNA
Sector
P/E ratio
--
25.58x
PEG ratio
--
0.00x
P/B ratio
1.53x
1.91x
Price / LTM sales
3.64x
1.90x
Growth Metrics
MRNA
Sector
Revenue growth
3.81%
7.28%
Earnings growth
--
1.42%
Revenue (5-year growth)
122.99%
8.73%
Earnings forecast
-$2.76
-$0.18
Profitability
MRNA
Sector
Profitability FY 2023
$2.1B
$57.2M
Return on invested capital
-17.44%
-14.35%
Return on assets
-12.92%
-11.83%
Return on equity
-17.44%
-15.32%
Earnings Date
Last Earnings Date
Nov
7
Next Earnings Date
Feb
21
Estimated Next Earnings Date
Feb
6
Balance Sheet
MRNA
Sector
Total cash
$6.9B
$46.4M
Short term investments
$5.7B
$44M
Total assets
$18.4B
$140.9M
Long term debt
--
$6.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Disney vs Estée Lauder Stock, Which Is Best?
Inflation has eaten away at a lot of the money…
Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
57
NARI alert for Jan 8
Inari Medical [NARI] is down 0.23% over the past day.
Buy
69
UNF alert for Jan 8
UniFirst [UNF] is up 4.97% over the past day.
Sell
31
APOG alert for Jan 8
Apogee Enterprises [APOG] is down 8.78% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
